Concepedia

Siena Tabuena-Frolli

ST

Statistics

Publications

2

Citations

48

H-Index

2

Active since

2021

Affiliations

Agilent Technologies (United States)(Current)

Siena Tabuena-Frolli is an author at Agilent Technologies (United States) specializing in cancer biomarkers, oncology, and medicine.

Publications per year

2021–2022

2

Publications

2

Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx

Megan Kalpakoff, Stephanie Hund, Jeanette Musser et al. · Applied immunohistochemistry & molecular morphology · 2021 · 28 citations · Full text

, , +14

A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone

Monika D. Polewski, Gitte Blach Nielsen, Ying Gu et al. · Applied immunohistochemistry & molecular morphology · 2022 · 20 citations · Full text

, , +17

1–2 of 2